The global insulin pens market size was valued at USD 7.46 billion in 2024 and is projected to reach from USD 8.05 billion in ...

Diabetes is a chronic condition that occurs when the body loses its ability to keep the level of sugar in the blood under ...

From wearable glucose monitors to AI-driven health insights, recent advances are giving patients new ways to manage blood ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The addition of AI into healthcare is something that has been a controversial decision as many people believe there is still ...